使用全自动深度学习体积分割工具在增强CT上对肝脂肪变性进行分类:以平扫CT为参考标准在1204名健康成人中的评估
该研究将全自动深度学习体积肝脾分割算法应用于1204名健康成人的平扫和增强CT,以平扫CT估计的PDFF为参考标准。结果显示,增强CT肝衰减和肝脾衰减差预测中度脂肪变性(PDFF≥15%)的AUC分别达0.962和0.986,对轻度脂肪变性(PDFF≥5%)的AUC较低(0.669和0.662)。结论认为该自动化工具可能有助于肝脂肪变性的客观分类评估,但需在不同扫描方案和厂商设备上进一步确认。
要点
- 增强CT肝衰减<90 HU提示存在脂肪变性(PDFF≥5%),该阈值诊断中度脂肪变性(PDFF≥15%)的敏感度75.9%、特异度95.7%。
- 增强CT肝脾衰减差<5 HU诊断中度脂肪变性(PDFF≥15%)的敏感度91.4%、特异度95.0%。
- 增强CT对中度脂肪变性(PDFF≥15%)的预测效能高(AUC 0.962–0.986),对轻度脂肪变性(PDFF≥5%)效能较低(AUC 0.662–0.669)。
诊断标准与关键数值
- 以平扫CT估计PDFF为参考,PDFF≥5%(轻度脂肪变性)、≥10%、≥15%(中度脂肪变性)分别占50.1%(n=603)、12.5%(n=151)、4.8%(n=58)。
- 增强CT肝衰减预测PDFF阈值5%、10%、15%的ROC AUC分别为0.669、0.854、0.962;增强CT肝脾衰减差对应的AUC分别为0.662、0.866、0.986。
- 增强CT肝衰减<90 HU诊断中度脂肪变性(PDFF≥15%)的敏感度75.9%、特异度95.7%;该阈值下96.8%(90/93)的患者存在脂肪变性(PDFF≥5%)。
- 增强CT肝衰减<100 HU诊断任何脂肪变性(PDFF≥5%)的敏感度34.0%、特异度94.2%。
- 增强CT肝脾衰减差≤10 HU的患者中93.8%(30/32)存在中度脂肪变性(PDFF≥15%);肝脾衰减差<5 HU诊断中度脂肪变性的敏感度91.4%、特异度95.0%。
临床应用与阅片要点
- 在增强CT阅片时,可参考肝衰减<90 HU或肝脾衰减差<5 HU提示中度脂肪变性(PDFF≥15%),但需注意这些阈值对轻度脂肪变性(PDFF≥5%)的敏感度较低(34.0%和29.5%)。
- 全自动深度学习体积分割工具可提供客观的肝脾衰减测量,可能有助于个体化和群体性脂肪变性评估,但原文指出需在不同扫描方案和厂商设备上进一步确认。
局限性
- 原文结论指出需在不同扫描方案和厂商设备上进一步确认。
- 原文临床影响部分指出,若这些结果在独立患者样本中得到确认,该自动化方法可能有用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Hepatic attenuation at unenhanced CT is linearly correlated with the MRI proton density fat fraction (PDFF). Liver fat quantification at contrast-enhanced CT is more challenging. OBJECTIVE. The purpose of this article is to evaluate liver steatosis categorization on contrast-enhanced CT using a fully automated deep learning volumetric hepatosplenic segmentation algorithm and unenhanced CT as the reference standard. METHODS. A fully automated volumetric hepatosplenic segmentation algorithm using 3D convolutional neural networks was applied to unenhanced and contrast-enhanced series from a sample of 1204 healthy adults (mean age, 45.2 years; 726 women, 478 men) undergoing CT evaluation for renal donation. The mean volumetric attenuation was computed from all designated liver and spleen voxels. PDFF was estimated from unenhanced CT attenuation and served as the reference standard. Contrast-enhanced attenuations were evaluated for detecting PDFF thresholds of 5% (mild steatosis, 10% and 15% (moderate steatosis); PDFF less than 5% was considered normal. RESULTS. Using unenhanced CT as reference, estimated PDFF was ≥ 5% (mild steatosis), ≥ 10%, and ≥ 15% (moderate steatosis) in 50.1% (n = 603), 12.5% (n = 151) and 4.8% (n = 58) of patients, respectively. ROC AUC values for predicting PDFF thresholds of 5%, 10%, and 15% using contrast-enhanced liver attenuation were 0.669, 0.854, and 0.962, respectively, and using contrast-enhanced liver-spleen attenuation difference were 0.662, 0.866, and 0.986, respectively. A total of 96.8% (90/93) of patients with contrast-enhanced liver attenuation less than 90 HU had steatosis (PDFF ≥ 5%); this threshold of less than 90 HU achieved sensitivity of 75.9% and specificity of 95.7% for moderate steatosis (PDFF ≥ 15%). Liver attenuation less than 100 HU achieved sensitivity of 34.0% and specificity of 94.2% for any steatosis (PDFF ≥ 5%). A total of 93.8% (30/32) of patients with contrast-enhanced liver-spleen attenuation difference 10 HU or less had moderate steatosis (PDFF ≥ 15%); a liver-spleen difference less than 5 HU achieved sensitivity of 91.4% and specificity of 95.0% for moderate steatosis. Liver-spleen difference less than 10 HU achieved sensitivity of 29.5% and specificity of 95.5% for any steatosis (PDFF ≥ 5%). CONCLUSION. Contrast-enhanced volumetric hepatosplenic attenuation derived using a fully automated deep learning CT tool may allow objective categoric assessment of hepatic steatosis. Accuracy was better for moderate than mild steatosis. Further confirmation using different scanning protocols and vendors is warranted. CLINICAL IMPACT. If these results are confirmed in independent patient samples, this automated approach could prove useful for both individualized and population-based steatosis assessment.
引用
- Pickhardt PJ, Blake GM, Graffy PM, et al. Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard. AJR Am J Roentgenol. 2020. PMID: 32936018. doi:10.2214/AJR.20.24415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。